These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 26228654)

  • 1. De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
    Idowu MO; Chhatrala R; Siddiqui MB; Driscoll C; Stravitz RT; Sanyal AJ; Bhati C; Sargeant C; Luketic VA; Sterling RK; Contos M; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 Nov; 21(11):1395-402. PubMed ID: 26228654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
    Chhatrala R; Siddiqui MB; Stravitz RT; Driscoll C; Sanyal A; Sargeant C; Luketic V; Sharma A; Sterling R; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 May; 21(5):623-30. PubMed ID: 25762084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
    Siddiqui MS; Sterling RK; Luketic VA; Puri P; Stravitz RT; Bouneva I; Boyett S; Fuchs M; Sargeant C; Warnick GR; Grami S; Sanyal AJ
    Gastroenterology; 2013 Dec; 145(6):1271-9.e1-3. PubMed ID: 23973920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients.
    Siddiqui MB; Arshad T; Patel S; Lee E; Albhaisi S; Sanyal AJ; Stravitz RT; Driscoll C; Sterling RK; Reichman T; Bhati C; Siddiqui MS
    Hepatology; 2019 Jul; 70(1):98-107. PubMed ID: 30672598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of hepatic steatosis to atherogenic dyslipidemia.
    Makadia SS; Blaha M; Keenan T; Ndumele C; Jones S; DeFilippis A; Martin S; Kohli P; Conceicao R; Carvalho J; Nasir K; Blumenthal R; Santos RD
    Am J Cardiol; 2013 Nov; 112(10):1599-604. PubMed ID: 24012029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.
    Siddiqui MS; Fuchs M; Idowu MO; Luketic VA; Boyett S; Sargeant C; Stravitz RT; Puri P; Matherly S; Sterling RK; Contos M; Sanyal AJ
    Clin Gastroenterol Hepatol; 2015 May; 13(5):1000-8.e3. PubMed ID: 25311381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
    Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
    Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
    Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
    J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.
    Toledo FG; Sniderman AD; Kelley DE
    Diabetes Care; 2006 Aug; 29(8):1845-50. PubMed ID: 16873790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome after pediatric liver transplantation.
    Kosola S; Lampela H; Makisalo H; Lohi J; Arola J; Jalanko H; Pakarinen M
    Liver Transpl; 2014 Oct; 20(10):1185-92. PubMed ID: 24923737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.
    Hoogeveen RC; Gaubatz JW; Sun W; Dodge RC; Crosby JR; Jiang J; Couper D; Virani SS; Kathiresan S; Boerwinkle E; Ballantyne CM
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1069-77. PubMed ID: 24558110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance.
    Miksztowicz V; Lucero D; Zago V; Cacciagiú L; Lopez G; Gonzalez Ballerga E; Sordá J; Fassio E; Schreier L; Berg G
    Diabetes Metab Res Rev; 2012 Sep; 28(6):535-41. PubMed ID: 22539458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Bartuli A; Manco M; Lopez R; Alisi A; Feldstein AE
    Pediatr Res; 2010 Jun; 67(6):665-70. PubMed ID: 20496475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients.
    Zeljkovic A; Vekic J; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z; Peco-Antic A; Kostic M; Vasic D; Spasic S
    Transpl Int; 2011 Nov; 24(11):1094-102. PubMed ID: 21848901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.